Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jul 27;321(4):205-12.
doi: 10.1056/NEJM198907273210401.

Bone marrow transplantation after the Chernobyl nuclear accident

Affiliations

Bone marrow transplantation after the Chernobyl nuclear accident

A Baranov et al. N Engl J Med. .

Erratum in

  • N Engl J Med 1990 Jan 25;322(4):280

Abstract

On April 26, 1986, an accident at the Chernobyl nuclear power station in the Soviet Union exposed about 200 people to large doses of total-body radiation. Thirteen persons exposed to estimated total-body doses of 5.6 to 13.4 Gy received bone marrow transplants. Two transplant recipients, who received estimated doses of radiation of 5.6 and 8.7 Gy, are alive more than three years after the accident. The others died of various causes, including burns (the cause of death in five), interstitial pneumonitis (three), graft-versus-host disease (two), and acute renal failure and adult respiratory distress syndrome (one). There was hematopoietic (granulocytic) recovery in nine transplant recipients who could be evaluated, six of whom had transient partial engraftment before the recovery of their own marrow. Graft-versus-host disease was diagnosed clinically in four persons and suspected in two others. Although the recovery of endogenous hematopoiesis may occur after exposure to radiation doses of 5.6 to 13.4 Gy, we do not know whether it is more likely after the transient engraftment of transplanted stem cells. Because large doses of radiation affect multiple systems, bone marrow recovery does not necessarily ensure survival. Furthermore, the risk of graft-versus-host disease must be considered when the benefits of this treatment are being weighed.

PubMed Disclaimer

Comment in

  • Chernobyl: learning from experience.
    Cassel CK, Leaning J. Cassel CK, et al. N Engl J Med. 1989 Jul 27;321(4):254-5. doi: 10.1056/NEJM198907273210409. N Engl J Med. 1989. PMID: 2747761 No abstract available.

Similar articles

Cited by

LinkOut - more resources